My Nonprofit Reviews

CancerSurvivor - charity reviews, charity ratings, best charities, best nonprofits, search nonprofits


188 profile views
1 reviews

Review for Cancer Research Institute, Inc., New York, NY, USA

Rating: 5 stars  

I give this organization my top rating because I am very familiar with the work they do. I was a participant in a cancer vaccine trial that was underwritten by the Cancer Research Institute. I know that this trial would not have happened without the research grant from CRI.

As a result of the clinical trial I participated in 7 years ago, I am still in remission from ovarian cancer today, and I am extremely grateful to CRI for their support of this small research study.

I have also had the opportunity to meet their staff and attend some fundraising events. They have a lean, well run organization with an admirably high percentage of funds going directly to grants for cancer immunotherapy research. I have also personally met several of the research scientists they support, and these are internationally known researchers with excellent credentials. They all say how important the financial support of CRI has been in making it possible to conduct their groundbreaking studies.

CRI has a fascinating website too, with some really great information on recent advances in cancer immunotherapy. Some of the current successes out there now such as Gardisil (cervical cancer vaccine) and Provenge (prostate cancer vaccine) came from researcher studies CRI helped to underwrite. A recently approved vaccine to prevent recurrence in melanoma is the latest CRI supported research effort on its way to the consumer market. So they are really accomplishing a lot.

This is a first-rate charity. It is one of the few I would actually contribute money to, because of their great track record in supporting cancer immunotherapy research, the many successes that have come out of the studies they help to fund, and the high standards they meet as a charitable organization.

Role:  Client Served & I was a participant in a cancer vaccine trial underwritten by CRI.